Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Japanese Subjects With Intestinal Behçet's Disease
NCT01243671Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2010
- Primary completion
- Mar 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in Behçet's disease (BD), sponsored by AbbVie Inc.. Started Oct 2010; status: completed.
02
Drugs
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on NCT01243671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243671.